Patrice Rioux

Insider · Other role · MNPR

Patrice Rioux files insider transactions with the SEC as an other role of Monopar Therapeutics (MNPR). We hold 1 disclosed purchase or sale filed since 17 April 2009, 1 of them in the last 90 days.

Files forMNPR
Disclosed buys and sells1 in all, 1 in the last 90 days
Last disclosure27 August 2026

Positions held

4 posts we hold — a term names its own dates; a run of filings only says when they filed

Filed 30 January 2020 — 26 August 2026Other role · Monopar Therapeutics (MNPR)11 Form 4 lines · source: SEC Form 4
Filed 30 December 2018 — 26 November 2019Other role · Monopar Therapeutics (NONE)5 Form 4 lines · source: SEC Form 4
Filed 16 April 2009 — 25 September 2012Chief Medical Officer · Raptor Pharmaceutical (RPTP)12 Form 4 lines · source: SEC Form 4
Filed 29 September 2009 — 29 September 2009Other role · Raptor Pharmaceutical (RPTPD)1 Form 4 line · source: SEC Form 4

Everything they disclosed

29 entries, newest first — one per disclosure report, one per Form 4 line

exercised options over 1,380 shares of Monopar TherapeuticsSEC Form 427 August 2026Common Stock · traded 26 August 2026 · filed 27 August 2026
▼ sold on the open market 1 share of Monopar TherapeuticsSEC Form 427 August 2026Common Stock · traded 26 August 2026 · filed 27 August 2026
exercised options over 1,380 shares of Monopar Therapeutics (a derivative holding)SEC Form 427 August 2026Stock Option · traded 26 August 2026 · filed 27 August 2026
was granted 2,000 shares of Monopar Therapeutics (a derivative holding)SEC Form 45 January 2026Stock Option · traded 1 January 2026 · filed 5 January 2026
was granted 2,000 shares of Monopar Therapeutics (a derivative holding)SEC Form 45 January 2026Stock Option · traded 1 January 2026 · filed 5 January 2026
was granted 2,000 shares of Monopar Therapeutics (a derivative holding)SEC Form 42 January 2025Stock Options · traded 1 January 2025 · filed 2 January 2025
was granted 10,000 shares of Monopar Therapeutics (a derivative holding)SEC Form 43 January 2024Stock Options · traded 1 January 2024 · filed 3 January 2024
was granted 10,000 shares of Monopar Therapeutics (a derivative holding)SEC Form 43 January 2023Stock Options · traded 1 January 2023 · filed 3 January 2023
was granted 10,000 shares of Monopar Therapeutics (a derivative holding)SEC Form 44 January 2022Stock Options · traded 1 January 2022 · filed 4 January 2022
was granted 10,000 shares of Monopar Therapeutics (a derivative holding)SEC Form 45 January 2021Stock options · traded 1 January 2021 · filed 5 January 2021
was granted 6,125 shares of Monopar Therapeutics (a derivative holding)SEC Form 420 February 2020Stock Options · traded 30 January 2020 · filed 20 February 2020
exercised options over 18,333 shares of Monopar Therapeutics (a derivative holding)SEC Form 426 November 2019Stock options · traded 26 November 2019 · filed 26 November 2019
exercised options over 100 shares of Monopar Therapeutics (a derivative holding)SEC Form 426 November 2019Stock options · traded 26 November 2019 · filed 26 November 2019
exercised options over 18,333 shares of Monopar TherapeuticsSEC Form 426 November 2019Common Stock · traded 26 November 2019 · filed 26 November 2019
exercised options over 100 shares of Monopar TherapeuticsSEC Form 426 November 2019Common Stock · traded 26 November 2019 · filed 26 November 2019
was granted 20,000 shares of Monopar Therapeutics (a derivative holding)SEC Form 425 January 2019Stock option · traded 30 December 2018 · filed 25 January 2019
was granted 67,000 shares of Raptor Pharmaceutical (a derivative holding)SEC Form 428 September 2012Stock options (right to buy) · traded 25 September 2012 · filed 28 September 2012
exercised options over 25,497 shares of Raptor Pharmaceutical (a derivative holding)SEC Form 413 April 2012Stock options (right to buy) · traded 13 April 2012 · filed 13 April 2012
exercised options over 25,497 shares of Raptor PharmaceuticalSEC Form 413 April 2012Common Stock · traded 13 April 2012 · filed 13 April 2012
was granted 37,872 shares of Raptor Pharmaceutical (a derivative holding)SEC Form 428 September 2011Stock options (right to buy) · traded 22 September 2011 · filed 28 September 2011
was granted 113,616 shares of Raptor Pharmaceutical (a derivative holding)SEC Form 428 September 2011Stock options (right to buy) · traded 22 September 2011 · filed 28 September 2011
was granted 37,872 shares of Raptor Pharmaceutical (a derivative holding)SEC Form 426 September 2011Stock options (right to buy) · traded 22 September 2011 · filed 26 September 2011
was granted 113,616 shares of Raptor Pharmaceutical (a derivative holding)SEC Form 426 September 2011Stock options (right to buy) · traded 22 September 2011 · filed 26 September 2011
was granted 113,616 shares of Raptor Pharmaceutical (a derivative holding)SEC Form 423 November 2010Stock options (right to buy) · traded 22 November 2010 · filed 23 November 2010
was granted 56,808 shares of Raptor Pharmaceutical (a derivative holding)SEC Form 413 October 2010Stock Options (right to buy) · traded 12 October 2010 · filed 13 October 2010
was granted 11,656 shares of Raptor Pharmaceutical (a derivative holding)SEC Form 49 July 2010Stock Option (right to buy) · traded 28 June 2010 · filed 9 July 2010
was granted 11,656 shares of Raptor Pharmaceutical (a derivative holding)SEC Form 41 April 2010Stock Option (right to buy) · traded 30 March 2010 · filed 1 April 2010
was granted 34,968 shares of Raptor Pharmaceutical (a derivative holding)SEC Form 41 October 2009Common Stock · traded 29 September 2009 · filed 1 October 2009
was granted 150,000 shares of Raptor Pharmaceuticals (a derivative holding)SEC Form 417 April 2009Employee Stock Options (Right to Buy) · traded 16 April 2009 · filed 17 April 2009

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.